Huntington’s disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive and psychiatric symptoms. As glutamate has been shown to be a potential biomarker of neurodegenerative diseases, we used Chemical Exchange Saturation Transfer imaging of glutamate (gluCEST) to map cerebral glutamate distribution in a rat model of HD. The longitudinal follow-up of brain glutamate levels reveals different variations between HD and control animals, suggesting that gluCEST may serve as a potential biomarker of HD, especially at asymptomatic stage.
This abstract and the presentation materials are available to members only; a login is required.